This paper is in the following e-collection/theme issue:

Protocols for Public Health Research and Surveillance (81) HIV/AIDS/STI Prevention and Care (935) LGBTQ Issues (490) Prevention and Health Promotion (1109) mHealth in the Developing World/LMICs, Underserved Communities, and for Global Health (621) Online Dating, Sexual Health Behavior (174)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/44961, first published .
Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

Authors of this article:

Beatriz Grinsztejn1 Author Orcid Image ;   Thiago Silva Torres1 Author Orcid Image ;   Brenda Hoagland1 Author Orcid Image ;   Emilia Moreira Jalil1 Author Orcid Image ;   Ronaldo Ismerio Moreira1 Author Orcid Image ;   Gabrielle O'Malley2 Author Orcid Image ;   Starley B Shade3 Author Orcid Image ;   Marcos R Benedetti1 Author Orcid Image ;   Julio Moreira4 Author Orcid Image ;   Keila Simpson5 Author Orcid Image ;   Maria Cristina Pimenta6 Author Orcid Image ;   Valdiléa Gonçalves Veloso1 Author Orcid Image ;   The ImPrEP CAB-Brasil Study Team7
Article Authors Cited by (3) Tweetations (2) Metrics
All Time | Last Month | Last Six Months | Last Year
JMIR Publications JMIR Publications @jmirpub

JMIR Public Health: Long-Acting Injectable Cabotegravir for #HIV Preexposure Prophylaxis Among Sexual and Gender Mi… https://t.co/H4tFrZOlos

3:01 PM · Apr 19, 2023

5
1
JMIR Public Health and Surveillance JMIR Public Health and Surveillance @JMIR_PH

RT @jmirpub: JMIR Public Health: Long-Acting Injectable Cabotegravir for #HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: P…

3:01 PM · Apr 19, 2023

5
1